<DOC>
	<DOCNO>NCT01475682</DOCNO>
	<brief_summary>Subjects Obstructive Sleep Apnea ( OSA ) increase risk develop cardiometabolic complication , effective long-term nCPAP treatment significantly reduce risk cardiovascular morbidity mortality .</brief_summary>
	<brief_title>Long Term Cardiovascular Complications Men With Obstructive Sleep Apnea</brief_title>
	<detailed_description>1 . Primary outcome : Incidence cardiometabolic diseases subject OSA 9 year . 2 . Secondary outcome : Effects CPAP treatment cardiometabolic condition</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Metabolic Diseases</mesh_term>
	<criteria>From previous cohort reassessment . Unstable medical condition</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Obstructive sleep apnea</keyword>
	<keyword>cardiometabolic complication</keyword>
	<keyword>Effects CPAP treatment</keyword>
</DOC>